Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats
Abstract Background Increased oxidative stress and impaired antioxidant defense are important mechanisms in the pathogenesis of diabetic myopathy. Alpha-lipoic acid (ALA) has been indicated as a weight-loss treatment in rodents and humans, but studies are limited. In the present study, we aimed to d...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-09-01
|
| Series: | Nutrition & Metabolism |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12986-018-0302-y |
| _version_ | 1818155895868096512 |
|---|---|
| author | Oak-Kee Hong Jang-Won Son Hyuk-Sang Kwon Seong-Su Lee Sung-Rae Kim Soon Jib Yoo |
| author_facet | Oak-Kee Hong Jang-Won Son Hyuk-Sang Kwon Seong-Su Lee Sung-Rae Kim Soon Jib Yoo |
| author_sort | Oak-Kee Hong |
| collection | DOAJ |
| description | Abstract Background Increased oxidative stress and impaired antioxidant defense are important mechanisms in the pathogenesis of diabetic myopathy. Alpha-lipoic acid (ALA) has been indicated as a weight-loss treatment in rodents and humans, but studies are limited. In the present study, we aimed to determine the influence of ALA, a potent biological antioxidant, on metabolic and growth processes in diabetic rat skeletal muscle. Methods Male 25-week-old type 2 diabetic rats (OLETF) were randomly divided into two groups, a control group (OLETF-C) and an ALA-treated group (OLETF-ALA) supplemented with 100 mg/kg ALA for 8 weeks. Age-matched, healthy, nondiabetic LETO (LETO-C) rats were used as controls. Results At 32 weeks of age, body weight was decreased by 6.8%, and the areas under the curve of IP-GTT, fasting glucose, and insulin were less in OLETF-ALA rats compared with OLETF-C rats. ALA significantly preserved muscle mass and enhanced muscle fiber cross-sectional area and fiber frequency percentage in the skeletal muscle of OLETF rats. Although the activation of myoD, myogenin, and myostatin in gastrocnemius muscle was significantly inhibited in OLETF-ALA rats relative to OLETF-C rats, there were no differences in the expression levels of muscle atrogin-1 and MuRF1 between the two groups. ALA treatment significantly increased the levels of phosphorylated 5′-AMPK, SIRT1, and PGC-1α, as well as the levels of phosphorylated AKT, mTOR, and p70S6 kinase in OLETF-ALA rats compared with OLETF-C rats. In contrast, the levels of phosphorylated p38 MAPK, IRS-1, and FOXO1 were decreased in OLETF-ALA rats compared with OLETF-C rats. Conclusions ALA treatment preserved mass in the gastrocnemius muscles of OLETF rats. ALA significantly upregulated the AMPK/SIRT1/PGC-1α and AKT/mTOR/p70S6K signaling pathways in OLETF rat skeletal muscle. Therefore, ALA may be a potential therapeutic intervention for skeletal muscle loss in animal models of insulin resistance. |
| first_indexed | 2024-12-11T14:49:41Z |
| format | Article |
| id | doaj.art-b29be16ca40f4283bb45b1773277e735 |
| institution | Directory Open Access Journal |
| issn | 1743-7075 |
| language | English |
| last_indexed | 2024-12-11T14:49:41Z |
| publishDate | 2018-09-01 |
| publisher | BMC |
| record_format | Article |
| series | Nutrition & Metabolism |
| spelling | doaj.art-b29be16ca40f4283bb45b1773277e7352022-12-22T01:01:32ZengBMCNutrition & Metabolism1743-70752018-09-0115111110.1186/s12986-018-0302-yAlpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF ratsOak-Kee Hong0Jang-Won Son1Hyuk-Sang Kwon2Seong-Su Lee3Sung-Rae Kim4Soon Jib Yoo5Department of Internal Medicine, College of Medicine, The Catholic University of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of KoreaAbstract Background Increased oxidative stress and impaired antioxidant defense are important mechanisms in the pathogenesis of diabetic myopathy. Alpha-lipoic acid (ALA) has been indicated as a weight-loss treatment in rodents and humans, but studies are limited. In the present study, we aimed to determine the influence of ALA, a potent biological antioxidant, on metabolic and growth processes in diabetic rat skeletal muscle. Methods Male 25-week-old type 2 diabetic rats (OLETF) were randomly divided into two groups, a control group (OLETF-C) and an ALA-treated group (OLETF-ALA) supplemented with 100 mg/kg ALA for 8 weeks. Age-matched, healthy, nondiabetic LETO (LETO-C) rats were used as controls. Results At 32 weeks of age, body weight was decreased by 6.8%, and the areas under the curve of IP-GTT, fasting glucose, and insulin were less in OLETF-ALA rats compared with OLETF-C rats. ALA significantly preserved muscle mass and enhanced muscle fiber cross-sectional area and fiber frequency percentage in the skeletal muscle of OLETF rats. Although the activation of myoD, myogenin, and myostatin in gastrocnemius muscle was significantly inhibited in OLETF-ALA rats relative to OLETF-C rats, there were no differences in the expression levels of muscle atrogin-1 and MuRF1 between the two groups. ALA treatment significantly increased the levels of phosphorylated 5′-AMPK, SIRT1, and PGC-1α, as well as the levels of phosphorylated AKT, mTOR, and p70S6 kinase in OLETF-ALA rats compared with OLETF-C rats. In contrast, the levels of phosphorylated p38 MAPK, IRS-1, and FOXO1 were decreased in OLETF-ALA rats compared with OLETF-C rats. Conclusions ALA treatment preserved mass in the gastrocnemius muscles of OLETF rats. ALA significantly upregulated the AMPK/SIRT1/PGC-1α and AKT/mTOR/p70S6K signaling pathways in OLETF rat skeletal muscle. Therefore, ALA may be a potential therapeutic intervention for skeletal muscle loss in animal models of insulin resistance.http://link.springer.com/article/10.1186/s12986-018-0302-yAlpha-lipoic acidDiabetic ratDiabetes mellitusSkeletal muscleMuscle mass |
| spellingShingle | Oak-Kee Hong Jang-Won Son Hyuk-Sang Kwon Seong-Su Lee Sung-Rae Kim Soon Jib Yoo Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats Nutrition & Metabolism Alpha-lipoic acid Diabetic rat Diabetes mellitus Skeletal muscle Muscle mass |
| title | Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats |
| title_full | Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats |
| title_fullStr | Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats |
| title_full_unstemmed | Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats |
| title_short | Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats |
| title_sort | alpha lipoic acid preserves skeletal muscle mass in type 2 diabetic oletf rats |
| topic | Alpha-lipoic acid Diabetic rat Diabetes mellitus Skeletal muscle Muscle mass |
| url | http://link.springer.com/article/10.1186/s12986-018-0302-y |
| work_keys_str_mv | AT oakkeehong alphalipoicacidpreservesskeletalmusclemassintype2diabeticoletfrats AT jangwonson alphalipoicacidpreservesskeletalmusclemassintype2diabeticoletfrats AT hyuksangkwon alphalipoicacidpreservesskeletalmusclemassintype2diabeticoletfrats AT seongsulee alphalipoicacidpreservesskeletalmusclemassintype2diabeticoletfrats AT sungraekim alphalipoicacidpreservesskeletalmusclemassintype2diabeticoletfrats AT soonjibyoo alphalipoicacidpreservesskeletalmusclemassintype2diabeticoletfrats |